Differential modulation of behavioral effects of cocaine by low-and high-efficacy D-1 agonists

被引:41
作者
Spealman, RD
Bergman, J
RosenzweigLipson, S
机构
[1] Harvard Medical School, New England Reg. Primate Res. Center, Box 9102, Southborough, MA 01772-9102, One Pine Hill Drive
[2] CNS Division, Wyeth-Ayerst Research, CN-8000, Princeton
关键词
cocaine; dopamine; D-1; agonists; D-1 partial agonists; antagonists; efficacy; schedule-controlled behavior; cocaine discrimination; SKF; 38393; 75670; 81297; 82958; 83189; SCH; 39166; squirrel monkeys;
D O I
10.1007/s002130050403
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine D-1 agonists differing in efficacy with respect to stimulation of adenylate cyclase activity and other in vitro and in vivo criteria were evaluated for their capacity to modulate the behavioral effects of cocaine in squirrel monkeys. Monkeys were trained either to respond on a fixed-ratio schedule in which lever pressing terminated a stimulus associated with electric shock or to discriminate cocaine from vehicle using a two-lever drug-discrimination procedure. When administered in combination with cocaine, D-1 agonists displaying relatively low efficacy (SKF 38393, SKF 75670) attenuated both the rate-altering effects of cocaine on fixed-ratio responding and the discriminative-stimulus effects of cocaine, resulting in overall rightward shifts of the cocaine dose-response functions. Maximal attenuation of the behavioral effects of cocaine by the D-1 partial agonises was comparable to that produced by the D-1 antagonist SCH 39166. In contrast, D-1 agonists displaying relatively high efficacy (SKF 81297, SKF 82958, SKF 83189) either had little effect on or accentuated the rate-altering and discriminative-stimulus effects of cocaine. The results show that D-1 partial agonists can act as functional cocaine antagonists and may be viable candidate medications for the management of cocaine addiction.
引用
收藏
页码:283 / 292
页数:10
相关论文
共 66 条
[1]   DOPAMINE RECEPTOR AGONISTS - SELECTIVITY AND DOPAMINE-D1 RECEPTOR EFFICACY [J].
ANDERSEN, PH ;
JANSEN, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (06) :335-347
[2]   INTRINSIC ACTIVITY - PARTIAL AGONISTS AND PARTIAL ANTAGONISTS [J].
ARIENS, EJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 :S8-S15
[3]   RELATIVE DOPAMINE D1 AND D2 RECEPTOR AFFINITY AND EFFICACY DETERMINE WHETHER DOPAMINE AGONISTS INDUCE HYPERACTIVITY OR ORAL STEREOTYPY IN RATS [J].
ARNT, J ;
BOGESO, KP ;
HYTTEL, J ;
MEIER, E .
PHARMACOLOGY & TOXICOLOGY, 1988, 62 (03) :121-130
[4]  
Barrett-Larimore R. L., 1996, Society for Neuroscience Abstracts, V22, P925
[5]  
BARRETTLARIMORE RL, 1997, IN PRESS NIDA RES MO
[6]  
BERGMAN J, 1995, J PHARMACOL EXP THER, V273, P40
[7]  
Bergman J, 1992, NIDA Res Monogr, V119, P185
[8]  
Bergman J, 1996, J PHARMACOL EXP THER, V276, P942
[9]  
Bergson C, 1995, J NEUROSCI, V15, P7821
[10]  
CALLAHAN PM, 1993, J PHARMACOL EXP THER, V266, P585